Published online before print October 13, 2005, doi: 10.1161/01.RES.0000190590.31545.d4
© 2005 American Heart Association, Inc.
Integrative Physiology |
Platelet-Derived Growth Factor D Induces Cardiac Fibrosis and Proliferation of Vascular Smooth Muscle Cells in Heart-Specific Transgenic Mice
From the Ludwig Institute for Cancer Research, Stockholm Branch, Sweden.
Correspondence to Ulf Eriksson, Ludwig Institute for Cancer Research, Stockholm Branch, Box 240, S-17177 Stockholm, Sweden. E-mail ulf.eriksson{at}licr.ki.se
Platelet-derived growth factor (PDGF)-D is a member of the PDGF/vascular endothelial growth factor family that activates PDGF receptor ß (PDGFR-ß). We show that PDGF-D is highly expressed in the myocardium throughout development and adulthood, as well as by arterial vascular smooth muscle cells (vSMCs). To obtain further knowledge regarding the in vivo response to PDGF-D, we generated transgenic mice overexpressing the active core domain of PDGF-D in the heart. Transgenic PDGF-D stimulates proliferation of cardiac interstitial fibroblasts and arterial vSMCs. This results in cardiac fibrosis followed by dilated cardiomyopathy and subsequent cardiac failure. Transgenic mice also display vascular remodeling, including dilation of vessels, increased density of SMC-coated vessels, and proliferation of vSMCs, leading to a thickening of tunica media. The thickening of arterial walls is a unique feature of PDGF-D, because this is not seen when PDGF-C is overexpressed in the heart. These results show that PDGF-D, via PDGFR-ß signaling, is a potent modulator of both vascular and connective tissue growth and may provide both paracrine and autocrine stimulation of PDGFR-ß. Our data raise the possibility that this growth factor may be involved in cardiac fibrosis and atherosclerosis.
Key Words: platelet-derived growth factor D • vascular smooth muscle cell • transgenic mice • cardiac fibrosis
This article has been cited by other articles:
 |
|
 |
|
  R. Tuuminen, A. I. Nykanen, R. Krebs, J. Soronen, K. Pajusola, M. A.I. Keranen, P. K. Koskinen, K. Alitalo, and K. B. Lemstrom PDGF-A, -C, and -D but not PDGF-B Increase TGF-{beta}1 and Chronic Rejection in Rat Cardiac Allografts Arterioscler. Thromb. Vasc. Biol., May 1, 2009; 29(5): 691 - 698. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Manso, S.-M. Kang, S. V. Plotnikov, I. Thievessen, J. Oh, H. E. Beggs, and R. S. Ross Cardiac fibroblasts require focal adhesion kinase for normal proliferation and migration Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H627 - H638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Thomas, R. A. Deaton, N. E. Hastings, Y. Shang, C. W. Moehle, U. Eriksson, S. Topouzis, B. R. Wamhoff, B. R. Blackman, and G. K. Owens PDGF-DD, a novel mediator of smooth muscle cell phenotypic modulation, is upregulated in endothelial cells exposed to atherosclerosis-prone flow patterns Am J Physiol Heart Circ Physiol, February 1, 2009; 296(2): H442 - H452. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Mellgren, C. L. Smith, G. S. Olsen, B. Eskiocak, B. Zhou, M. N. Kazi, F. R. Ruiz, W. T. Pu, and M. D. Tallquist Platelet-Derived Growth Factor Receptor {beta} Signaling Is Required for Efficient Epicardial Cell Migration and Development of Two Distinct Coronary Vascular Smooth Muscle Cell Populations Circ. Res., December 5, 2008; 103(12): 1393 - 1401. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Leipner, K. Grun, A. Muller, E. Buchdunger, L. Borsi, H. Kosmehl, A. Berndt, T. Janik, A. Uecker, M. Kiehntopf, et al. Imatinib mesylate attenuates fibrosis in coxsackievirus b3-induced chronic myocarditis Cardiovasc Res, July 1, 2008; 79(1): 118 - 126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Andrae, R. Gallini, and C. Betsholtz Role of platelet-derived growth factors in physiology and medicine Genes & Dev., May 15, 2008; 22(10): 1276 - 1312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Burstein, E. Libby, A. Calderone, and S. Nattel Differential Behaviors of Atrial Versus Ventricular Fibroblasts: A Potential Role for Platelet-Derived Growth Factor in Atrial-Ventricular Remodeling Differences Circulation, April 1, 2008; 117(13): 1630 - 1641. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Burstein and S. Nattel Atrial Fibrosis: Mechanisms and Clinical Relevance in Atrial Fibrillation J. Am. Coll. Cardiol., February 26, 2008; 51(8): 802 - 809. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Boor, A. Konieczny, L. Villa, U. Kunter, C. R.C. van Roeyen, W. J. LaRochelle, G. Smithson, S. Arrol, T. Ostendorf, and J. Floege PDGF-D inhibition by CR002 ameliorates tubulointerstitial fibrosis following experimental glomerulonephritis Nephrol. Dial. Transplant., May 1, 2007; 22(5): 1323 - 1331. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kappert, J. Paulsson, J. Sparwel, O. Leppanen, C. Hellberg, A. Ostman, and P. Micke Dynamic changes in the expression of DEP-1 and other PDGF receptor-antagonizing PTPs during onset and termination of neointima formation FASEB J, February 1, 2007; 21(2): 523 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. C.H. Hsieh, C. MacGillivray, J. Gannon;, F. U. Cruz, and R. T. Lee Local Controlled Intramyocardial Delivery of Platelet-Derived Growth Factor Improves Postinfarction Ventricular Function Without Pulmonary Toxicity Circulation, August 15, 2006; 114(7): 637 - 644. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. W.M. Schellings, M. Baumann, R. E.W. van Leeuwen, R. F.J.J. Duisters, S. H.P. Janssen, B. Schroen, C. J. Peutz-Kootstra, S. Heymans, and Y. M. Pinto Imatinib Attenuates End-Organ Damage in Hypertensive Homozygous TGR(mRen2)27 Rats Hypertension, March 1, 2006; 47(3): 467 - 474. [Abstract] [Full Text] [PDF]
|
|